Red-Backed Vole Brain Promotes Highly Efficient In Vitro Amplification of Abnormal Prion Protein from Macaque and Human Brains Infected with Variant Creutzfeldt-Jakob Disease Agent

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Nemecek, Julie ^a   Nag, Nabanita ^a   Carlson, Christina M ^b,c   Schneider, Jay R ^b   Heisey, Dennis M ^b   Johnson, Christopher J ^b   Asher, David M ^a   Gregori, Luisa ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL WILDLIFE HEALTH CENTER   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MACACA; MICROTUS PENNSYLVANICUS; MYODES GLAREOLUS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; RED BACKED VOLE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ARVICOLINAE; BRAIN; CODON; CREUTZFELDT-JAKOB SYNDROME; HUMANS; MACACA; PERFUSION; POLYMORPHISM, GENETIC; PRPSC PROTEINS;

EID: 84886259820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078710     Document Type: Article

References (36)

1. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, et al. (1997) The same prion strain causes vCJD and BSE. Nature 389: 448-450. doi:10.1038/38925. PubMed: 9333232.
2. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389: 498-501. doi:10.1038/39057. PubMed: 9333239.
3. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417-421. doi:10.1016/S0140-6736(04)15486-X. PubMed: 14962520.
4. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW, (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527-529. doi:10.1016/S0140-6736(04)16811-6. PubMed: 15302196.
5. UK Health Protection Agency (2006) New case of transfusion-associated variant-CJD in the United Kingdom. Eurosurveillance 11(6). Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2895. Accessed 2013 September 24.
6. UK Health Protection Agency (2007) Fourth case of transfusion-associated variant-CJD infection in the United Kingdom. Eurosurveillance 12(3). Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3117. Accessed 2013 September 24.
7. Peden A, McCardle L, Head MW, Love S, Ward HJ, et al. (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16: 296-304. doi:10.1111/j.1365-2516.2009.02181.x. PubMed: 20070383.
8. UK Health Protection Agency (2012) Summary results of the second national survey of abnormal prion prevalence in archived appendix specimens. Available: http://www.hpa.org.uk/hpr/archives/2012/news3212.htm#bnrmlprn. Accessed 2013 September 24.
9. Advisory Committee on Dangerous Pathogens (2012) SE Risk Assessment Subgroup Position Statement on occurrence of vCJD and prevalence of infection in the UK population.
10. Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, et al. (2011) Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377: 487-493. doi:10.1016/S0140-6736(10)62308-2. PubMed: 21295339.
11. Orrú CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, et al. (2011) Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. mBio 2(3):: e00078-11. doi:10.1128/MBio.00078-11. PubMed: 21558432. 2011.
12. Rubenstein R, Chang B, Gray P, Piltch M, Bulgin MS, et al. (2010) A novel method for preclinical detection of PrPSc in blood. J Gen Virol 91: 1883-1892. doi:10.1099/vir.0.020164-0. PubMed: 20357038.
13. Gregori L, Gray BN, Rose E, Spinner DS, Kascsak RJ, Rohwer RG, (2008) A sensitive and quantitative assay for normal PrP in plasma. J Virol Methods 149: 251-259. doi:10.1016/j.jviromet.2008.01.028. PubMed: 18339433.
14. Chen B, Morales R, Barria MA, Soto C, (2010) Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods 7: 519-520. doi:10.1038/nmeth.1465. PubMed: 20512142.
15. Gregori L, Yang H, Anderson S, (2011) Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood. Transfusion 51: 2596-2602. doi:10.1111/j.1537-2995.2011.03199.x. PubMed: 21645006.
16. Orrù CD, Wilham JM, Vascellari S, Hughson AG, Caughey B, (2012) New generation QuIC assays for prion seeding activity. Prion 6: 147-152. doi:10.4161/pri.19430. PubMed: 22421206.
17. Castilla J, Saá P, Morales R, Abid K, Maundrell K, Soto C, (2006) Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 412: 3-21. doi:10.1016/S0076-6879(06)12001-7. PubMed: 17046648.
18. Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, et al. (2008) Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5: 211-212. doi:10.1038/nmeth0308-211. PubMed: 18309304.
19. Morales R, Duran-Aniotz C, Diaz-Espinoza R, Camacho MV, Soto C, (2012) Protein misfolding cyclic amplification of infectious prions. Nat Protoc 7: 1397-1409. doi:10.1038/nprot.2012.067. PubMed: 22743831.
20. Castilla J, Saá P, Soto C, (2005) Detection of prions in blood. Nat Med 11: 982-985. PubMed: 16127436.
21. Jones M, Peden AH, Prowse CV, Gröner A, Manson JC, Turner ML, et al. (2007) In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 213: 21-26. doi:10.1002/path.2204. PubMed: 17614097.
22. Saá P, Castilla J, Soto C, (2006) Presymptomatic detection of prions in blood. Science 313: 92-94. doi:10.1126/science.1129051. PubMed: 16825570.
23. Thorne L, Terry LA, (2008) In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89: 3177-3184. doi:10.1099/vir.0.2008/004226-0. PubMed: 19008409.
24. Cooper JK, Ladhani K, Minor P, (2012) Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets. Vox Sang 102: 100-109. doi:10.1111/j.1423-0410.2011.01525.x. PubMed: 22126309.
25. Minor P, Newham J, Jones N, Bergeron C, Gregori L, et al. (2004) Standards for the assay of Creutzfeldt-Jakob disease specimens. J Gen Virol 85: 1777-1784. doi:10.1099/vir.0.79959-0. PubMed: 15166463. doi:10.1099/vir.0.79959-0 PubMed: 15166463.
26. Cosseddu GM, Nonno R, Vaccari G, Bucalossi C, Fernandez-Borges N, et al. (2011) Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLOS Pathog 7(11):: e1002370. doi:10.1371/journal.ppat.1002370. PubMed: 22114554.
27. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernández-Borges N, et al. (2010) A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 120: 2590-2599. doi:10.1172/JCI42051. PubMed: 20551516.
28. Kurt TD, Telling GC, Zabel MD, Hoover EA, (2009) Trans-species amplification of PrP(CWD) and correlation with rigid loop 170N. Virology 3871: 235-243. PubMed: 19269662.
29. Kurt TD, Seelig DM, Schneider JR, Johnson CJ, Telling GC, et al. (2011) Alteration of the chronic wasting disease species barrier by in vitro prion amplification. J Virol 85: 8528-8537. doi:10.1128/JVI.00809-11. PubMed: 21697475.
30. Jones M, Peden AH, Wight D, Prowse C, Macgregor I, et al. (2008) Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Neuroreport 19: 1783-1786. doi:10.1097/WNR.0b013e328318edfa. PubMed: 18955905.
31. Castilla J, Morales R, Saá P, Barria M, Gambetti P, Soto C, (2008) Cell-free propagation of prion strains. EMBO J 27: 2557-2566. doi:10.1038/emboj.2008.181. PubMed: 18800058.
32. Jones M, Wight D, Barron R, Jeffrey M, Manson J, et al. (2009) Molecular model of prion transmission to humans. Emerg Infect Dis 15: 2013-2016. doi:10.3201/eid1512.090194. PubMed: 19961689.
33. Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, et al. (2006) Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLOS Pathog 2(2):: e12. doi:10.1371/journal.ppat.0020012. PubMed: 16518470.
34. Agrimi U, Nonno R, Dell'Omo G, Di Bari MA, Conte M, et al. (2008) Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles. PLOS Pathog: 4(7):: e1000113. doi:10.1371/journal.ppat.1000113. PubMed: 18654630.
35. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, et al. (2011) Highly efficient protein misfolding cyclic amplification. PLOS Pathog 7(2):: e1001277. doi:10.1371/journal.ppat.1001277. PubMed: 21347353.
36. Johnson CJ, Aiken JM, McKenzie D, Samuel MD, Pedersen JA, (2012) Highly efficient amplification of chronic wasting disease agent by protein misfolding cyclic amplification with beads (PMCAb). PLOS ONE 7(4):: e35383. doi:10.1371/journal.pone.0035383. PubMed: 22514738.